CONCERNING PRESCRIPTION DRUG COST TRANSPARENCY. Requires health carriers, pharmacy benefit managers, pharmacy services administrative organizations, and drug manufacturers to report certain prescription drug pricing data to the Health Care Authority (HCA). Requires manufacturers to provide advance notice to the HCA before increasing the price of certain drugs. Requires the HCA to analyze the data and provide an annual report to the Legislature.